Latest Breaking News On - Yasir rawjee - Page 2 : comparemela.com

Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra) [India], September 22: Glenmark Pharmaceuticals Limited ("Glenmark Pharma"), a research-led, integrated, global pharmaceutical company has entered into a definitive agreement with Nirma Limited to divest 75% stake in its subsidiary, Glenmark Life Sciences Limited ("GLS"), at a price of INR 615/- per share for an aggregate consideration of INR 56,515 mn, subject to closing adjustments. Glenmark Pharma own 7.84% in GLS after the divestment. The transaction is subject to customary closing conditions precedent, including receipt of regulatory and shareholder approvals. Business News | Glenmark Pharma Announces Proposed Divestment of Majority Stake in Glenmark Life Sciences.

Glenn saldanhaGlenmark pharmaYasir rawjeeGlenmark life sciences limitedBiosimilars companiesGlenmark life sciencesIndian pharmaceuticalsGlenmark pharmaceuticals limited pharmaGlenmark pharmaceuticals limitedglenmark limitedGlenmark pharmaceuticalsLinkedin glenmark pharmaceuticalsBsr associatesGlenmark pharmaceuticals limitedNirma limitedTatiana maslany birthdayManaging director